In MCAO mice, the stimulation of α7nAChRs with their agonist choline resulted in an increased expression of α7nAChRs, as well as a reduction in infarct volume and neurological deficits, supporting the therapeutic potential of cholinergic modulation in promoting post-stroke neurofunctional recovery [142]. The gene discussed is CHRNA7; the disease is stroke disorder.